跳至主要内容
临床试验/NCT06690736
NCT06690736招募中不适用

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

Tianjin Medical University3 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
3
主要终点
Standardized uptake value (SUV)

研究概览

简要总结

To evaluate the potential usefulness of 68Ga/18F-Pentixafor/Pentixather positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various CXCR4-related disease patients.

详细描述

Subjects with various CXCR4-related disease patients underwent 68Ga/18F-Pentixafor/Pentixather PET/CT either for an initial assessment or for recurrence detection. Lesions uptake was quantified by the maximum standard uptake value (SUVmax). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 68Ga/18F-Pentixafor/Pentixather PET/CT were calculated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • suspected or confirmed untreated Lymphoproliferative and other CXCR4-related diseases patients
  • 18F-FDG PET/CT within two weeks
  • signed written consent.

排除标准

  • pregnancy
  • breastfeeding
  • known allergy against Pentixafor

研究组 & 干预措施

CXCR4 PET/CT Imaging

Experimental

Intravenous injection of one dose of 2-5 mCi 68Ga/18F-Pentixafor/Pentixather. Tracer doses of radiotracers will be used to image lesions by PET/CT

干预措施: CXCR4 PET/CT Imaging (Diagnostic Test)

结局指标

主要结局

Standardized uptake value (SUV)

时间窗: 30 days

Standardized uptake value (SUV) of FAPI for each target lesion of subject or suspected primary tumor or/and metastasis.

次要结局

  • Diagnostic efficacy(30 days)

研究者

发起方
Tianjin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaobo Yao, PhD

Prof.

Tianjin Medical University

研究点 (3)

Loading locations...

相似试验